INCYTE CORPORATION revenue breakdown overview

INCYTE CORPORATION revenue for the last year amounted to 88.43 B MXN, the most of which — 88.96 B MXN — came from its highest performing source at the moment, Oncology and Dermatology Pharmaceutical Products, the year earlier bringing 62.49 B MXN. The greatest contribution to the revenue figure was made by United States — last year it brought INCYTE CORPORATION 83.40 B MXN, and the year before that — 59.45 B MXN.